Lillys position is that the Courts prior case-management rulings narrowed only Issue 3 , which concerns general causation, and did not similarly restrict the scope of Issue 2
Pharmacological stimulation of brain carnitine palmitoyl-transferase-1 (CPT-1) was reported to decrease food intake and body weight [75]
weight loss* Zepbound mimics two natural hormones, GLP-1 and GIP, to help you feel full and reduce hunger
This makes subjective symptoms, like muscle cramps, poor sleep, irritability, and heart palpitations, important diagnostic clues
animal studies suggest it may support healing of gastric ulcers and damaged intestinal lining Preclinical models suggest it may help modulate inflammation, though this has not been established in controlled human trials Known risks and side effects: Because it is sold as an unregulated research chemical rather than a manufactured pharmaceutical, product purity and dosing accuracy cannot be verified, and the FDA has flagged potential impurities and manufacturing-quality concerns FDA's Category 2 determination specifically cited potential immune reactions and hypersensitivity as a safety concern User-reported (non-clinical-trial) effects include injection-site irritation, redness, or swelling, along with occasional headache, nausea, or lightheadedness, based on anecdotal reporting rather than controlled studies No long-term human safety data exists